Premium
Pilot Study of the Pharmacokinetics of Methylprednisolone After Single and Multiple Intravenous Doses of Methylprednisolone Sodium Succinate and Methylprednisolone Suleptanate to Healthy Volunteers
Author(s) -
Ferry James J.,
DellaColetta Andrew A.,
Weber Dennis J.,
VanderLugt James T.
Publication year - 1994
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/j.1552-4604.1994.tb01988.x
Subject(s) - methylprednisolone , prodrug , pharmacokinetics , pharmacology , dosing , medicine , corticosteroid , chemistry , anesthesia
The pharmacokinetics of methylprednisolone were evaluated in 29 healthy volunteers after multiple intravenous doses of methylprednisolone sodium succinate or the novel prodrug, methylprednisolone suleptanate. Subjects were assigned randomly to one of four treatment groups (40, 100, 250, or 500 mg) and then randomly assigned to receive either the sodium succinate or suleptanate prodrugs. Doses were administered every 6 hours for 48 hours. Plasma and urine were assayed for methylprednisolone and unchanged prodrug using HPLC methods. Methylprednisolone pharmacokinetics exhibited both a dose and time dependency, which was similar for administration of both prodrugs. After first‐dose administration, mean clearance increased from 19.5 L/hr for 40‐mg doses to 27.7 L/hr after 500‐mg doses of the sodium succinate ester, and from 20.1 to 31.7 L/hr after the suleptanate ester. After multiple dosing, mean clearance values increased from 31.1 to 44.7 L/hr for sodium succinate dosing, and from 31.5 to 46.0 L/hr for suleptanate dosing. Apparent systemic clearance values determined after multiple dosing were 1.5‐ to 1.8‐fold greater than corresponding first‐dose values. No dependence on time was apparent for any prodrug pharmacokinetic parameter. These data suggest that the dose dependency of methylprednisolone pharmacokinetics is related to dose‐dependent prodrug hydrolysis, whereas the time dependence possibly reflects auto‐induction of methylprednisolone metabolism. Based on comparison of methylprednisolone pharmacokinetic parameters derived for each prodrug, methylprednisolone suleptanate resulted in a faster and slightly more efficient conversion to methylprednisolone than methylprednisolone sodium succinate.